Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBT (2016 - 2026)

Re has reported EBT over the past 14 years, most recently at $28.7 million for Q4 2025.

  • Quarterly EBT rose 160.08% to $28.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.4 million through Dec 2025, up 221.96% year-over-year, with the annual reading at $45.4 million for FY2025, 221.96% up from the prior year.
  • EBT was $28.7 million for Q4 2025 at Re, up from $11.3 million in the prior quarter.
  • Over five years, EBT peaked at $59.8 million in Q4 2021 and troughed at -$47.7 million in Q4 2024.
  • The 5-year median for EBT is $2.9 million (2021), against an average of $787900.0.
  • Year-over-year, EBT surged 1188.85% in 2021 and then tumbled 8021.01% in 2023.
  • A 5-year view of EBT shows it stood at $59.8 million in 2021, then crashed by 97.56% to $1.5 million in 2022, then plummeted by 1328.65% to -$17.9 million in 2023, then plummeted by 166.17% to -$47.7 million in 2024, then surged by 160.08% to $28.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's EBT are $28.7 million (Q4 2025), $11.3 million (Q3 2025), and $6.9 million (Q2 2025).